3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
2
Solid Tumors
1
Myelodysplastic Syndromes
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Azacitidine
56
Cyclophosphamide
44
fludarabine phosphate
42
fludarabine
37
Decitabine
27
venetoclax
26
Cytarabine
25
Tacrolimus
20
Specimen Handling
18
Filgrastim
18
Busulfan
18
Melphalan
17
Whole-Body Irradiation
16
Mycophenolic Acid
16
Antilymphocyte Serum
14
Granulocyte Colony-Stimulating Factor
12
Clofarabine
12
Biopsy
12
Peripheral Blood Stem Cell Transplantation
11
Injections
11
Etoposide
11
Methotrexate
10
thymoglobulin
9
Thiotepa
9
Stem Cell Transplantation
9
Lenalidomide
9
decitabine and cedazuridine drug combination
8
aldesleukin
8
Sirolimus
8
Nivolumab
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Myelodysplastic Syndromes
×
glasdegib
×
Clear all
NCT02367456
2024-01-19
BRIGHT 1012
Pfizer
Phase 1
Completed
73 enrolled
31 charts